ID: ALA3649414

Max Phase: Preclinical

Molecular Formula: C29H33Cl2N3O7S

Molecular Weight: 638.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](NC(=O)[C@@H]1C[C@@H](S(=O)(=O)c2ccccc2Cl)CN1C(=O)C1(c2ccc(Cl)cc2)CC1)C(=O)C(=O)NCCOC

Standard InChI:  InChI=1S/C29H33Cl2N3O7S/c1-3-22(25(35)27(37)32-14-15-41-2)33-26(36)23-16-20(42(39,40)24-7-5-4-6-21(24)31)17-34(23)28(38)29(12-13-29)18-8-10-19(30)11-9-18/h4-11,20,22-23H,3,12-17H2,1-2H3,(H,32,37)(H,33,36)/t20-,22+,23+/m1/s1

Standard InChI Key:  KIDPFKMKRUSRRX-PUHATCMVSA-N

Associated Targets(Human)

CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.57Molecular Weight (Monoisotopic): 637.1416AlogP: 2.69#Rotatable Bonds: 12
Polar Surface Area: 138.95Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.56CX Basic pKa: CX LogP: 3.32CX LogD: 3.32
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.27Np Likeness Score: -0.97

References

1.  (2014)  Pyrrolidine derivatives, 

Source

Source(1):